Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
aut00063 (1 trial)
Deafness (Phase 2)
Hearing Loss (Phase 2)
Trials (1 total)
Trial APIs (1 total)